Reaction

Skin Laxity reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 405 reports · 5 co-occurring drugs

As of the last recalculation, Skin Laxity appears in 405 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is ASFOTASE ALFA (PRR 47.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Asfotase Alfa	9	47.2	47.2
Oral Semaglutide	35	26.7	26.7
Tirzepatide	47	16.8	16.8
Botulinum Toxin Type A	4	16.7	16.7
Onabotulinumtoxina	20	14.0	14.0

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.